Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials

Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder

To see complete record on, please visit this link

Id: NCT04141501

Organisation Name: University of Zurich

Overal Status: Recruiting

Start Date: June 8, 2020

Last Update: May 20, 2022

Lead Sponsor: University of Zurich

Brief Summary: Effects of serotonin 2A/1A receptor stimulation by psilocybin on alcohol addicted patients: a randomized double-blind placebo-controlled study

  • Alcohol Use Disorder

Total execution time in seconds: 0.26813817024231